Section Arrow
Quote
HBIO.NASDAQ
- Harvard Bioscience Inc.
Quotes are at least 15-min delayed:2026/07/06 00:34 EDT
Regular Hours
Last
 6.15
+0.1 (+1.65%)
Day High 
6.24 
Prev. Close
6.05 
1-M High
6.69 
Volume 
9.58K 
Bid
5.53
Ask
6.69
Day Low
5.94 
Open
6.19 
1-M Low
5.7651 
Market Cap 
27.29M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.03 
20-SMA 6.12 
50-SMA 6.13 
52-W High 9.4 
52-W Low 3.755 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.15/0.36
Enterprise Value
70.04M
Balance Sheet
Book Value Per Share
2.23
Cash Flow
Cash Flow Yield
0.11
Income Statement
Total Revenue
86.55M
Operating Revenue Per Share
24.95
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc43.19+1.46+3.50%36.51PE
AVTRAvantor10.32+0.31+3.10%-- 
BAXBaxter International22.65+0.96+4.43%-- 
XRAYDENTSPLY SIRONA11.65+0.56+5.05%-- 
COOCooper Companies (The)74.2+2.25+3.13%60.97PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction andin vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.